PYRIMIDINONES AS FACTOR XIA INHIBITORS
The present invention provides a compound which is (9R,13S)-13-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-6-oxo-1,6-dihydropyrimidin-1-yl}-3-(difluoromethyl)-9-methyl-3,4,7,15-tetraazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one trifluoroacetate, or a stereoisomer or ta...
Saved in:
Main Authors | , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
09.11.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention provides a compound which is (9R,13S)-13-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-6-oxo-1,6-dihydropyrimidin-1-yl}-3-(difluoromethyl)-9-methyl-3,4,7,15-tetraazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one trifluoroacetate, or a stereoisomer or tautomer thereof. This invention also relates to pharmaceutical compositions comprising this compound and their use in the treatment of thromboembolic disorders. |
---|---|
AbstractList | The present invention provides a compound which is (9R,13S)-13-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-6-oxo-1,6-dihydropyrimidin-1-yl}-3-(difluoromethyl)-9-methyl-3,4,7,15-tetraazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one trifluoroacetate, or a stereoisomer or tautomer thereof. This invention also relates to pharmaceutical compositions comprising this compound and their use in the treatment of thromboembolic disorders. |
Author | WEXLER, Ruth R SMITH II, Leon M PINTO, Donald J.P DE LUCCA, Indawati YANG, Wu CORTE, James R WANG, Yufeng FANG, Tianan PABBISETTY, Kumar Balashanmuga ORWAT, Michael J DILGER, Andrew K EWING, William R ZHU, Yeheng |
Author_xml | – fullname: ZHU, Yeheng – fullname: ORWAT, Michael J – fullname: PABBISETTY, Kumar Balashanmuga – fullname: CORTE, James R – fullname: YANG, Wu – fullname: SMITH II, Leon M – fullname: DILGER, Andrew K – fullname: WANG, Yufeng – fullname: PINTO, Donald J.P – fullname: FANG, Tianan – fullname: DE LUCCA, Indawati – fullname: EWING, William R – fullname: WEXLER, Ruth R |
BookMark | eNrjYmDJy89L5WRQC4gM8vT1dPH08_dzDVZwDFZwc3QO8Q9SiPB0VPD08_B08gTygnkYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSbxrgLGBhaWluaWjoTERSgBx_yUn |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | PYRIMIDINONE ALS FAKTOR-XIA-HEMMER PYRIMIDINONES UTILISÉES EN TANT QU'INHIBITEURS DU FACTEUR XIA |
ExternalDocumentID | EP3089979A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_EP3089979A13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 12:50:17 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French German |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_EP3089979A13 |
Notes | Application Number: EP20150747721 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20161109&DB=EPODOC&CC=EP&NR=3089979A1 |
ParticipantIDs | epo_espacenet_EP3089979A1 |
PublicationCentury | 2000 |
PublicationDate | 20161109 |
PublicationDateYYYYMMDD | 2016-11-09 |
PublicationDate_xml | – month: 11 year: 2016 text: 20161109 day: 09 |
PublicationDecade | 2010 |
PublicationYear | 2016 |
RelatedCompanies | BRISTOL-MYERS SQUIBB COMPANY |
RelatedCompanies_xml | – name: BRISTOL-MYERS SQUIBB COMPANY |
Score | 3.058809 |
Snippet | The present invention provides a compound which is... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | PYRIMIDINONES AS FACTOR XIA INHIBITORS |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20161109&DB=EPODOC&locale=&CC=EP&NR=3089979A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8MwDLamgYAbDBDjpRxQbxXpY30cKtSnWqS1VVtQOU20pNIuY2JF_H2cqBtc4JaH5CRWvtiOYwfgzm71rp3pimxob6aMm4LKDUoKWWHMoBqjaisuc-apET_pj_WsHsFyGwsj8oR-ieSIiKgW8d6L83r9c4kViLeVm_tmiU3vD1HlBNJgHaP6olBbCjwnzLMg8yXfx5KUFo7G3Vum7aKhtIdatMnBED57PChl_VuiRMewnyOxVX8CI7aawKG__XhtAgfzwd-NxQF6m1OQ8pcCD5ogSbM0LIlbksj1q6wgdeKSJI0TL8FaeQYkCis_lnHAxW5xizDfTU07hzHa_OwCiGXpSmdaesPTw3T2K_8Nw1RUVBcoU1tqTWH6J5nLf_qu4IhzSQTT2dcw7j8-2Q1K1b65Ffz4Buhudj8 |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8MwDLamgRg3GCDGMwfUW0Vf6-NQoT7VwvpQW1A5TbRLpV3GxIr4-7hRN7jALQ_JSax8sR3HDsCdUStNPVVEXpUXGo-bQuArlBS8SKkqyFSQanaZE8Vq8Kw8ltNyAMttLAzLE_rFkiMiomrEe8vO6_XPJZbL3lZu7qslNr0_-IXpcr11jOqLKBica5temriJwzkOlrg4M-XOvaUZFhpKe6hhax0YvBe7C0pZ_5Yo_hHsp0hs1R7DgK7GMHK2H6-N4SDq_d1Y7KG3OQEufc3woHHDOIm9nFg58S2nSDJShhYJ4yC0Q6zlp0B8r3ACHgec7xY399Ld1OQzGKLNT8-B6LoiNpquVF16mMZ4637D0EQJ1QWBSrWgT2DyJ5mLf_puYRQU0Ww-C-OnSzjsOMYC64wrGLYfn_QaJWxb3TDefAOeqnky |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PYRIMIDINONES+AS+FACTOR+XIA+INHIBITORS&rft.inventor=ZHU%2C+Yeheng&rft.inventor=ORWAT%2C+Michael+J&rft.inventor=PABBISETTY%2C+Kumar+Balashanmuga&rft.inventor=CORTE%2C+James+R&rft.inventor=YANG%2C+Wu&rft.inventor=SMITH+II%2C+Leon+M&rft.inventor=DILGER%2C+Andrew+K&rft.inventor=WANG%2C+Yufeng&rft.inventor=PINTO%2C+Donald+J.P&rft.inventor=FANG%2C+Tianan&rft.inventor=DE+LUCCA%2C+Indawati&rft.inventor=EWING%2C+William+R&rft.inventor=WEXLER%2C+Ruth+R&rft.date=2016-11-09&rft.externalDBID=A1&rft.externalDocID=EP3089979A1 |